Adimab, Inc. Announces Series C Financing Published: Nov 20, 2008 LEBANON, N.H.--(BUSINESS WIRE)--Adimab, Inc., a leading antibody discovery company, today announced the closing of a Series C financing. The total amount of the financing was not disclosed. Related links BioSpace.com This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news
